After Medline pulled off a massive $6.26 billion IPO late last year, the company now finds itself facing serious concerns ...

Medline (Nasdaq:MDLN) has received a warning letter from the FDA related to NAMIC brand angiographic control syringes and ...

In the latest tranche of published warning letters, the US Food and Drug Administration (FDA) has continued to go after ...

By Rishika Sadam April 9 (Reuters) - Granules India is increasing oversight at its manufacturing facilities and digitising ...

FDA made clear that comments from ImmunityBio founder Dr. Patrick Soon-Shiong about prescription drugs in longform audio can trigger enforcement just like TV or digital ads. Regulators evaluated the ...

The enforcement action was announced alongside President Donald Trump's signing of a presidential memorandum.

The FDA warned against purchasing certain hyaluronic acid products for pain relief, citing potentially dangerous undeclared ...

A common drug combo for Parkinson’s disease will require a new FDA warning after the agency flagged 14 cases of seizures in patients using the medications. The agency is mandating (PDF) that ...

According to the FDA, ImmunityBio’s communications “create a misleading impression” that Anktiva can cure or prevent cancer ...

The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of Ozempic and Wegovy, alleging the drugmaker failed to report potential side effects in patients who ...

The US Food and Drug Administration (FDA) has warned an oncology drug company for repeatedly overstating the efficacy of its drug in advertisements while failing to adequately disclose the associated ...

Please provide your email address to receive an email when new articles are posted on . The FDA found “serious violations” of postmarketing adverse drug experience regulations at Novo Nordisk in 2025.